Yahoo Web Search

Search results

1. • 

     Bristol Myers' injectable form of Opdivo meets main goal in kidney cancer trial

     Reuters via AOL· 7 months ago

     The new formulation of the drug that was tested in the trial used Halozyme Therapeutics' proprietary...

2. • 

     Bristol Myers' (BMY) Opdivo SC Meets Kidney Cancer Study Goals

     Zacks via Yahoo Finance· 7 months ago

     Bristol Myers' (BMY) subcutaneous formulation of Opdivo, developed using Halozyme's Enhanze...

3. • 

     Bristol Myers (BMY) Fails to Meet Goal in Opdivo NSCLC Study

     Zacks via Yahoo Finance· 1 day ago

     Bristol Myers' (BMY) late-stage label-expanding study evaluating the Opdivo/Yervoy combination fails...

4. • 

     Bristol Myers' (BMY) Opdivo Label Expansion Filings Get Accepted

     Zacks via Yahoo Finance· 3 months ago

     Bristol Myers (BMY) announces the acceptance of its regulatory filings for the perioperative Opdivo...

5. • 

     Bristol Myers' (BMY) Opdivo sBLA Gets FDA's Priority Review

     Zacks via Yahoo Finance· 5 months ago

     Bristol Myers (BMY) announces that the FDA has accepted its sBLA for Opdivo to treat first-line...

6. • 

     Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning Point deal

     Reuters via Yahoo News· 2 years ago

     (Reuters) -Bristol Myers Squibb Co said on Friday it will acquire drug developer Turning Point...

7. • 

     2 Biotechs That Could Get Bought Out in 2024

     Motley Fool via Yahoo Finance· 4 months ago

     Big pharma is facing another round of major patent expirations. Before the decade's end, Bristol Myers Squibb (BMS) will lose exclusivity for the...

8. • 

     Bristol Myers (BMY) Up 20.4% YTD: Will the Momentum Continue?

     Zacks via Yahoo Finance· 2 years ago

     Shares of Bristol Myers BMY have jumped 20.4% in the year so far against the industry’s decline of...

9. • 

     Bristol Myers Squibb's Combo Therapy Shows Sustained Benefits Over Pfizer's Cancer Drug In Kidney...

     Benzinga via Yahoo Finance· 4 months ago

     Bristol Myers Squibb & Co (NYSE:BMY) announced that Opdivo (nivolumab) plus Yervoy (ipilimumab)...

10. • 

      Bristol Myers' (BMY) Opdivo Positive in Late-Stage NSCLC Study

      Zacks via Yahoo Finance· 8 months ago

      Bristol Myers' (BMY) perioperative regimen of neoadjuvant Opdivo with chemotherapy, followed by...